182 related articles for article (PubMed ID: 8946950)
21. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
[TBL] [Abstract][Full Text] [Related]
22. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity.
Deacon CF; Knudsen LB; Madsen K; Wiberg FC; Jacobsen O; Holst JJ
Diabetologia; 1998 Mar; 41(3):271-8. PubMed ID: 9541166
[TBL] [Abstract][Full Text] [Related]
23. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
Heller RS; Kieffer TJ; Habener JF
Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
[TBL] [Abstract][Full Text] [Related]
24. Solubilization of active receptors for glucagon-like peptide-1(7-36)amide from rat lung membranes.
Göke R; Kolligs F; Richter G; Lankat-Buttgereit B; Göke B
Am J Physiol; 1993 Feb; 264(2 Pt 1):L146-52. PubMed ID: 8383446
[TBL] [Abstract][Full Text] [Related]
25. Cloning and functional expression of a human glucagon-like peptide-1 receptor.
Graziano MP; Hey PJ; Borkowski D; Chicchi GG; Strader CD
Biochem Biophys Res Commun; 1993 Oct; 196(1):141-6. PubMed ID: 8216285
[TBL] [Abstract][Full Text] [Related]
26. Glucagon-like peptide-1 binding to rat skeletal muscle.
Delgado E; Luque MA; Alcántara A; Trapote MA; Clemente F; Galera C; Valverde I; Villanueva-Peñacarrillo ML
Peptides; 1995; 16(2):225-9. PubMed ID: 7784253
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo.
Kim JG; Baggio LL; Bridon DP; Castaigne JP; Robitaille MF; Jetté L; Benquet C; Drucker DJ
Diabetes; 2003 Mar; 52(3):751-9. PubMed ID: 12606517
[TBL] [Abstract][Full Text] [Related]
28. The primary ligand-binding interaction at the GLP-1 receptor is via the putative helix of the peptide agonists.
Al-Sabah S; Donnelly D
Protein Pept Lett; 2004 Feb; 11(1):9-14. PubMed ID: 14965273
[TBL] [Abstract][Full Text] [Related]
29. Solubilization of active GLP-1 (7-36)amide receptors from RINm5F plasma membranes.
Göke R; Oltmer B; Sheikh SP; Göke B
FEBS Lett; 1992 Apr; 300(3):232-6. PubMed ID: 1313374
[TBL] [Abstract][Full Text] [Related]
30. Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain.
West GM; Willard FS; Sloop KW; Showalter AD; Pascal BD; Griffin PR
PLoS One; 2014; 9(9):e105683. PubMed ID: 25180755
[TBL] [Abstract][Full Text] [Related]
31. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
[TBL] [Abstract][Full Text] [Related]
32. Signal transduction of the GLP-1-receptor cloned from a human insulinoma.
van Eyll B; Lankat-Buttgereit B; Bode HP; Göke R; Göke B
FEBS Lett; 1994 Jul; 348(1):7-13. PubMed ID: 7517895
[TBL] [Abstract][Full Text] [Related]
33. Ligand binding pocket formed by evolutionarily conserved residues in the glucagon-like peptide-1 (GLP-1) receptor core domain.
Moon MJ; Lee YN; Park S; Reyes-Alcaraz A; Hwang JI; Millar RP; Choe H; Seong JY
J Biol Chem; 2015 Feb; 290(9):5696-706. PubMed ID: 25561730
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
Runge S; Thøgersen H; Madsen K; Lau J; Rudolph R
J Biol Chem; 2008 Apr; 283(17):11340-7. PubMed ID: 18287102
[TBL] [Abstract][Full Text] [Related]
35. A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain.
Tibaduiza EC; Chen C; Beinborn M
J Biol Chem; 2001 Oct; 276(41):37787-93. PubMed ID: 11498540
[TBL] [Abstract][Full Text] [Related]
36. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors.
Brubaker PL; Drucker DJ
Recept Channels; 2002; 8(3-4):179-88. PubMed ID: 12529935
[TBL] [Abstract][Full Text] [Related]
37. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).
Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW
J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958
[TBL] [Abstract][Full Text] [Related]
38. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Diabetes; 2004 Sep; 53(9):2492-500. PubMed ID: 15331566
[TBL] [Abstract][Full Text] [Related]
39. Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets.
Kieffer TJ; Heller RS; Unson CG; Weir GC; Habener JF
Endocrinology; 1996 Nov; 137(11):5119-25. PubMed ID: 8895386
[TBL] [Abstract][Full Text] [Related]
40. The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists.
Al-Sabah S; Donnelly D
FEBS Lett; 2003 Oct; 553(3):342-6. PubMed ID: 14572647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
